Works matching IS 15228517 AND DT 2019 AND VI 21 AND IP 1

Results: 19
    1
    2

    Highlights from the Literature.

    Published in:
    Neuro-Oncology, 2019, v. 21, n. 1, p. 11, doi. 10.1093/neuonc/noy197
    By:
    • Soffietti, Riccardio;
    • Chamberlain, Marc;
    • Purow, Benjamin;
    • Bhat, Krishna;
    • Wright, Karen
    Publication type:
    Article
    3

    Forthcoming Meetings.

    Published in:
    Neuro-Oncology, 2019, v. 21, n. 1, p. 142, doi. 10.1093/neuonc/noy196
    Publication type:
    Article
    4
    5

    Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma.

    Published in:
    Neuro-Oncology, 2019, v. 21, n. 1, p. 47, doi. 10.1093/neuonc/noy123
    By:
    • Cho, Hee Jin;
    • Zhao, Junfei;
    • Jung, Sang Won;
    • Ladewig, Erik;
    • Kong, Doo-Sik;
    • Suh, Yeon-Lim;
    • Lee, Yeri;
    • Kim, Donggeon;
    • Ahn, Sun Hee;
    • Bordyuh, Mykola;
    • Kang, Hyun Ju;
    • Sa, Jason K;
    • Seo, Yun Jee;
    • Kim, Sung Tae;
    • Lim, Do Hoon;
    • Dho, Yun-Sik;
    • Lee, Jung-Il;
    • Seol, Ho Jun;
    • Choi, Jung Won;
    • Park, Woong-Yang
    Publication type:
    Article
    6
    7
    8
    9
    10

    N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma.

    Published in:
    Neuro-Oncology, 2019, v. 21, n. 1, p. 95, doi. 10.1093/neuonc/noy161
    By:
    • Wick, Wolfgang;
    • Dettmer, Susan;
    • Berberich, Anne;
    • Kessler, Tobias;
    • Karapanagiotou-Schenkel, Irini;
    • Wick, Antje;
    • Winkler, Frank;
    • Pfaff, Elke;
    • Brors, Benedikt;
    • Debus, Jürgen;
    • Unterberg, Andreas;
    • Bendszus, Martin;
    • Herold-Mende, Christel;
    • Eisenmenger, Andreas;
    • Deimling, Andreas von;
    • Jones, David T W;
    • Pfister, Stefan M;
    • Sahm, Felix;
    • Platten, Michael
    Publication type:
    Article
    11
    12
    13

    Sex-specific gene and pathway modeling of inherited glioma risk.

    Published in:
    Neuro-Oncology, 2019, v. 21, n. 1, p. 71, doi. 10.1093/neuonc/noy135
    By:
    • Ostrom, Quinn T;
    • Coleman, Warren;
    • Huang, William;
    • Rubin, Joshua B;
    • Lathia, Justin D;
    • Berens, Michael E;
    • Speyer, Gil;
    • Liao, Peter;
    • Wrensch, Margaret R;
    • Eckel-Passow, Jeanette E;
    • Armstrong, Georgina;
    • Rice, Terri;
    • Wiencke, John K;
    • McCoy, Lucie S;
    • Hansen, Helen M;
    • Amos, Christopher I;
    • Bernstein, Jonine L;
    • Claus, Elizabeth B;
    • Houlston, Richard S;
    • Il'yasova, Dora
    Publication type:
    Article
    14
    15

    Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group.

    Published in:
    Neuro-Oncology, 2019, v. 21, n. 1, p. 26, doi. 10.1093/neuonc/noy137
    By:
    • Huang, Raymond Y;
    • Bi, Wenya Linda;
    • Weller, Michael;
    • Kaley, Thomas;
    • Blakeley, Jaishri;
    • Dunn, Ian;
    • Galanis, Evanthia;
    • Preusser, Matthias;
    • McDermott, Michael;
    • Rogers, Leland;
    • Raizer, Jeffrey;
    • Schiff, David;
    • Soffietti, Riccardo;
    • Tonn, Jörg-Christian;
    • Vogelbaum, Michael;
    • Weber, Damien;
    • Reardon, David A;
    • Wen, Patrick Y
    Publication type:
    Article
    16
    17

    Nomograms based on preoperative multiparametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: results from a radiogenomics study of 111 patients.

    Published in:
    Neuro-Oncology, 2019, v. 21, n. 1, p. 115, doi. 10.1093/neuonc/noy093
    By:
    • Dasgupta, Archya;
    • Gupta, Tejpal;
    • Pungavkar, Sona;
    • Shirsat, Neelam;
    • Epari, Sridhar;
    • Chinnaswamy, Girish;
    • Mahajan, Abhishek;
    • Janu, Amit;
    • Moiyadi, Aliasgar;
    • Kannan, Sadhana;
    • Krishnatry, Rahul;
    • Sastri, Goda Jayant;
    • Jalali, Rakesh
    Publication type:
    Article
    18

    Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial.

    Published in:
    Neuro-Oncology, 2019, v. 21, n. 1, p. 106, doi. 10.1093/neuonc/noy091
    By:
    • Lassman, Andrew B;
    • Bent, Martin J van den;
    • Gan, Hui K;
    • Reardon, David A;
    • Kumthekar, Priya;
    • Butowski, Nicholas;
    • Lwin, Zarnie;
    • Mikkelsen, Tom;
    • Nabors, Louis B;
    • Papadopoulos, Kyriakos P;
    • Penas-Prado, Marta;
    • Simes, John;
    • Wheeler, Helen;
    • Walbert, Tobias;
    • Scott, Andrew M;
    • Gomez, Erica;
    • Lee, Ho-Jin;
    • Roberts-Rapp, Lisa;
    • Xiong, Hao;
    • Ansell, Peter J
    Publication type:
    Article
    19